160
Participants
Start Date
March 28, 2022
Primary Completion Date
April 3, 2024
Study Completion Date
April 3, 2024
GNR-069
Once a week as a subcutaneous injection.
"State Budgetary Institution of Healthcare of the city of Moscow Moscow Clinical Scientific and Practical Center named after A.S. Loginov Department of Health of the city of Moscow", Moscow
Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia), Moscow
"State budgetary health care institution of the city of Moscow City Clinical Hospital named after V.V. Veresaev of the Department of Health of the City of Moscow", Moscow
"Federal State Budgetary Institution National Medical Research Center named after V.A. Almazov of the Ministry of Health of the Russian Federation", Saint Petersburg
"State Budgetary Health Institution of the Kaluga Region Kaluga Regional Clinical Hospital", Kaluga
"State Health Institution of the Tula Region Tula Regional Clinical Hospital", Tula
"Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation", Rostov-on-Don
"Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Health of the Russian Federation", Ufa
"State budgetary institution of health care of the Nizhny Novgorod region Nizhny Novgorod Regional Clinical Hospital named after N. A. Semashko", Nizhny Novgorod
"Llc Medis", Nizhny Novgorod
"Municipal budgetary institution Central City Hospital No. 7", Yekaterinburg
"Federal State Budgetary Educational Institution of Higher Education Novosibirsk State Medical University of the Ministry of Health of the Russian Federation", Novosibirsk
"State Budgetary Institution of Healthcare Irkutsk awarded the Sign of Honor Order Regional Clinical Hospital", Irkutsk
AO GENERIUM
INDUSTRY